NICO.LAB’s CEO, Dr. Merel Boers co-founded the company in 2015 following the groundbreaking MR CLEAN trial. The first Randomized Clinical Trial that proved the benefit of Endovascular Treatment which led to a paradigm shift in acute stroke care and triaging.

Merel is an ambitious and inspiring entrepreneur as well as an innovative researcher. At a very young age Merel is driving NICO.LAB to internationalisation and great success.


Inhoud niet beschikbaar.
Accepteer cookiesdoor op Accepteren in de banner te klikken

Merel gained a huge amount of knowledge through her PhD in stroke imaging that led her to obtaining one of the highest honours, summa cum laude, in her research at the University of Twente. During her PhD working at the Academic Medical Center, Amsterdam, Merel and her research colleague, Renan Sales-Barros (co-founder and Chief Technology Officer of NICO.LAB) identified the opportunity and need to improve care for such a time critical disease.

Cookies helpen ons om inzicht in het gebruik van deze website te krijgen. Meer informatie

We gebruiken Google Analytics om inzicht te krijgen in het globale gebruik van deze website. We kunnen niet zien wie u bent, we kunnen alleen (anonieme) individuele gebruikers onderscheiden om te zien wie wat doet en wie bijvoorbeeld terugkomt op de website.